Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study
This study evaluated the efficacy and safety of tadalafil in pediatric patients with pulmonary arterial hypertension. This phase-3, international, randomized, multicenter (24 weeks double-blind placebo-controlled period; two-year, open-labeled extension period), add-on (patient’s current endothelin...
Guardado en:
Autores principales: | Dunbar Ivy, Damien Bonnet, Rolf MF Berger, Gisela M.B. Meyer, Simin Baygani, Baohui Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75942800a8a54901aee6b5024833fa15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
por: N. A. Geppe, et al.
Publicado: (2021) -
Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population
por: Elisa Barbieri, et al.
Publicado: (2021) -
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
por: Gary T. Ferguson, et al.
Publicado: (2017) -
Effect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: a single-blind randomized controlled trial
por: Iman A. Basheti, et al.
Publicado: (2017) -
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
por: Cowan J, et al.
Publicado: (2021)